Realistic pathologic classification of acute myeloid leukemias.
Most classification systems of acute myeloid leukemia (AML) rely largely on the criteria proposed by the French-American-British (FAB) Cooperative Group. The recently proposed World Health Organization (WHO) classification of neoplastic diseases of the hematopoietic and lymphoid tissues includes a classification of AMLs. The proposed WHO classification of AMLs includes traditional FAB-type categories of disease, as well as additional disease types that correlate with specific cytogenetic findings and AML associated with myelodysplasia. This system includes a large number of disease categories, many of which are of unknown clinical significance, and there seems to be substantial overlap between disease groups in the WHO proposal. Some disease types in the WHO proposal cannot be diagnosed without detailed clinical information, or they are diagnosed only by the cytogenetic findings. In this report, a realistic pathologic classification for AML is proposed that includes disease types that correlate with specific cytogenetic translocations and can be recognized reliably by morphologic evaluation and immunophenotyping and that incorporates the importance of associated myelodysplastic changes. This system would be supported by cytogenetic or molecular genetic studies and could be expanded as new recognizable clinicopathologic entities are described.
Arber
D A
DA
Division of Pathology, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA, USA.
D000208:Acute Disease; D002882:Chromosomes, Human, Pair 13; D002884:Chromosomes, Human, Pair 15; D006801:Humans; D016130:Immunophenotyping; D007621:Karyotyping; D007947:Leukemia, Megakaryoblastic, Acute / Q000175:diagnosis / Q000235:genetics / Q000473:pathology; D007951:Leukemia, Myeloid / Q000145:classification* / Q000235:genetics / Q000473:pathology*; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis / Q000235:genetics / Q000473:pathology; D014944:World Health Organization